Citurgia Biochemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Selling, General & Admin	1.69	1.69	1.69	1.62	1.6	1.4	Upgrade
Other Operating Expenses	1.64	0.28	0.81	0.48	0.19	2.33	Upgrade
Operating Expenses	5.59	4.23	4.76	4.36	4.04	6.12	Upgrade
Operating Income	-5.59	-4.23	-4.76	-4.36	-4.04	-6.12	Upgrade
Interest Expense	-0	-0	-0	-0	-0	-0	Upgrade
Pretax Income	-5.59	-4.23	-4.76	-4.36	-4.04	-6.12	Upgrade
Net Income	-5.59	-4.23	-4.76	-4.36	-4.04	-6.12	Upgrade
Net Income to Common	-5.59	-4.23	-4.76	-4.36	-4.04	-6.12	Upgrade
Shares Outstanding (Basic)	-	132	132	132	132	132	Upgrade
Shares Outstanding (Diluted)	-	132	132	132	132	132	Upgrade
EPS (Basic)	-	-0.03	-0.04	-0.03	-0.03	-0.05	Upgrade
EPS (Diluted)	-	-0.03	-0.04	-0.03	-0.03	-0.05	Upgrade
EBITDA	-3.33	-1.97	-2.5	-2.1	-1.78	-3.73	Upgrade
D&A For EBITDA	2.26	2.26	2.26	2.26	2.26	2.39	Upgrade
EBIT	-5.59	-4.23	-4.76	-4.36	-4.04	-6.12	Upgrade
Advertising Expenses	-	-	-	-	0.01	0.03	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.